动脉粥样硬化患者甘油三酯升高的管理中国专家共识要点与解读

被引：25

作者：

马依彤

机构：

[1] 新疆医科大学第一附属医院心脏中心

来源：

中国循环杂志 | 2019年 / 34(S1)卷 / S1期

关键词：

动脉粥样硬化; 血脂异常; 心血管疾病; 甘油三酯;

D O I：

暂无

中图分类号：

R543.5 [动脉疾病];

学科分类号：

100201 [内科学];

摘要：

<正>血脂异常是动脉粥样硬化(AS)发生、发展的重要因素之一。血脂异常的管理一直是动脉粥样硬化性心血管疾病(ASCVD)防控的重要方面,以降低低密度脂蛋白胆固醇(LDL-C)为靶目标的他汀类药物已是公认的抗ASCVD的基石。血浆甘油三酯(TG)水平升高与ASCVD的关系一直备受争议,而近期的基因学研究及大规模真实世界研究证据显示,TG水平与AS的发生明显相关。为了进一步提高国内广大医师对高甘油三酯血症(HTG)增加ASCVD发病风险的认识,规范和完善AS患者HTG的管理与干预,中华医学会心血管病学分会预防学组联合相

引用

页码：66 / 68

页数：3

共 11 条

[1]

高甘油三酯血症及其心血管风险管理专家共识.[J].中国胆固醇教育计划委员会;.中华心血管病杂志.2017, 02

[2]

中国成人血脂异常防治指南.[J]..中华心血管病杂志.2007, 05

[3]

Orthostatic Hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Blood Pressure Trial: Prevalence; Incidence; and Prognostic Significance.[J].Jerome L. Fleg;Gregory W. Evans;Karen L. Margolis;Joshua Barzilay;Jan N. Basile;J. Thomas Bigger;Jeffrey A. Cutler;Richard Grimm;Carolyn Pedley;Kevin Peterson;Rodica Pop-Busui;JoAnn Sperl-Hillen;William C. Cushman.Hypertension.2016,

[4]

Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study [J].

Forouhi, Nita G. ;

Imamura, Fumiaki ;

Sharp, Stephen J. ;

Koulman, Albert ;

Schulze, Matthias B. ;

Zheng, Jusheng ;

Ye, Zheng ;

Sluijs, Ivonne ;

Guevara, Marcela ;

Maria Huerta, Jose ;

Kroeger, Janine ;

Wang, Laura Yun ;

Summerhill, Keith ;

Griffin, Julian L. ;

Feskens, Edith J. M. ;

Affret, Aurelie ;

Amiano, Pilar ;

Boeing, Heiner ;

Dow, Courtney ;

Fagherazzi, Guy ;

Franks, Paul W. ;

Gonzalez, Carlos ;

Kaaks, Rudolf ;

Key, Timothy J. ;

Khaw, Kay Tee ;

Kuehn, Tilman ;

Mortensen, Lotte Maxild ;

Nilsson, Peter M. ;

Overvad, Kim ;

Pala, Valeria ;

Palli, Domenico ;

Panico, Salvatore ;

Ramon Quiros, J. ;

Rodriguez-Barranco, Miguel ;

Rolandsson, Olov ;

Sacerdote, Carlotta ;

Scalbert, Augustin ;

Slimani, Nadia ;

Spijkerman, Annemieke M. W. ;

Tjonneland, Anne ;

Tormo, Maria-Jose ;

Tumino, Rosario ;

van der A, Daphne L. ;

van der Schouw, Yvonne T. ;

Langenberg, Claudia ;

Riboli, Elio ;

Wareham, Nicholas J. .

PLOS MEDICINE, 2016, 13 (07)

[5]

Low alanine aminotransferase levels and higher number of cardiovascular events in people with Type 2 diabetes: analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study [J].

Williams, K. H. ;

Sullivan, D. R. ;

Veillard, A. S. ;

O'Brien, R. ;

George, J. ;

Jenkins, A. J. ;

Young, S. ;

Ehnholm, C. ;

Duffield, A. ;

Twigg, S. M. ;

Keech, A. C. .

DIABETIC MEDICINE, 2016, 33 (03) :356-364

[6]

The prevalence; awareness; treatment and control of dyslipidemia among adults in China.[J].Ling Pan;Zhenhua Yang;Yue Wu;Rui-Xing Yin;Yunhua Liao;Jinwei Wang;Bixia Gao;Luxia Zhang.Atherosclerosis.2016,

[7]

Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: The EpanoVa for Lowering Very high triglyceridEs (EVOLVE) trial [J].

Kastelein, John J. P. ;

Maki, Kevin C. ;

Susekov, Andrey ;

Ezhov, Marat ;

Nordestgaard, Borge G. ;

Machielse, Ben N. ;

Kling, Douglas ;

Davidson, Michael H. .

JOURNAL OF CLINICAL LIPIDOLOGY, 2014, 8 (01) :94-106

[8]

Steady-state bioavailability of prescription omega-3 on a low-fat diet is significantly improved with a free fatty acid formulation compared with an ethyl ester formulation: the ECLIPSE II study.[J].Elliot Offman;Michael Davidson;Danielle Curcio;Douglas Kling;Judith Johnson;Sandy Ferber;Ted Marenco.Vascular Health and Risk Management.2013, defa

[9]

Management of Severe Hypertriglyceridemia with a Novel Omega-3 Free- Fatty Acid Formulation: Subgroups in the EVOLVE Trial.[J].John J.P. Kastelein;Kevin Maki;Andrey Susekov;Marat Ezhov;Borge Nordestgaard;Douglas Kling;Michael H. Davidson.Journal of Clinical Lipidology.2013, 3

[10]

A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: The ECLIPSE (Epanova ? compared to Lovaza ? in a pharmacokinetic single-dose evaluation) study.[J].Michael H. Davidson;Judith Johnson;Michael W. Rooney;Michael L. Kyle;Douglas F. Kling.Journal of Clinical Lipidology.2012, 6

← 1 2 →